Antis Triantafyllides & Sons advises on the sale of shares in one of Egypt's fastest growing pharmaceutical companies  
Our firm advised the Egyptian American Enterprise Fund (“EAEF”) and its investment manager Lorax Capital Partners with respect to the acquisition of a significant stake in the Cyprus holding company of Orchidia Pharmaceutical Industries, the leading Egyptian ophthalmic generic medicine manufacturer and one of the fastest growing pharmaceutical companies in Egypt.
The firm advised and provided support throughout the transaction. Our team has carried out due diligence reports on the Cyprus holding companies, assisted with the review of sale and purchase agreements and share swapping agreements, drafted the articles of association and assisted with the closing formalities.